Skip to main content
SpringerLink
Log in

Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure

  • Correspondence
  • Published:
Journal of Cardiovascular Translational Research Aims and scope Submit manuscript

Abstract

Recently, novel findings about the interleukin 1β (IL-1 β) axis in acute decompensated heart failure (ADHF) have been published. There is a positive correlation between IL-1 β and interleukin-1 receptor like 1 (sST2) in ADHF patients. Is there also a correlation between the values of IL-1 β and sST2 in chronic heart failure patients?

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haugen, E., Gan, L. M., Isic, A., Skommevik, T., & Fu, M. (2008). Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Experimental & Clinical Cardiology, 13(1), 19–24.

    CAS  Google Scholar 

  2. Kosar, F., Aksoy, Y., Ozguntekin, G., Ozerol, I., & Varol, E. (2006). Relationship between cytokines and tumour markers in patients with chronic heart failure. European Journal of Heart Failure, 8(3), 270–274.

    Article  CAS  Google Scholar 

  3. Pascual-Figal, D. A., Bayes-Genis, A., Asensio-Lopez, M. C., Hernández-Vicente, A., Garrido-Bravo, I., Pastor-Perez, F., Díez, J., Ibáñez, B., & Lax, A. (2019). The interleukin-1 axis and risk of death in patients with acutely decompensated heart failure. Journal of the American College of Cardiology, 73(9), 1016–1025.

    Article  CAS  Google Scholar 

  4. Bayés-Genís, A., Núñez, J., & Lupón, J. (2017). Soluble ST2 for prognosis and monitoring in heart failure: the new gold standard? Journal of the American College of Cardiology, 70(19), 2389–2392.

    Article  Google Scholar 

  5. Ridker, P. M., Everett, B. M., Thuren, T., et al. (2017). Antiinflammatory therapy with canakinumab for atherosclerotic disease. The New England Journal of Medicine, 377, 1119–1131.

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported in part by grants from Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBER CV) CB16/11/00403 and CB16/11/00385.

Author information

Authors and Affiliations

  1. Heart Failure and Cardiac Regeneration (ICREC) Research Program, Health Science Research Institute Germans Trias i Pujol (IGTP), Badalona, Spain

    E Revuelta-López

  2. Centro de Investigación Biomédica en Red Enfermedades Cardiovaculares, CIBERCV, Madrid, Spain

    E Revuelta-López, J Lupón, DA Pascual-Figal & A Bayés-Genís

  3. Cardiology Service and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain

    J Lupón & A Bayés-Genís

  4. Cardiology Department, Hospital Virgen de la Arrixaca, Murcia, Spain

    A Lax & DA Pascual-Figal

  5. Universidad de Murcia, Murcia, Spain

    A Lax & DA Pascual-Figal

  6. Centro Nacional de Investigaciones Cardiovasculares, CNIC, Madrid, Spain

    DA Pascual-Figal

Authors
  1. E Revuelta-López
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Lupón
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Lax
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. DA Pascual-Figal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Bayés-Genís
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Bayés-Genís.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Ethical Approval

This study was conducted in accordance with the ethical standards of our institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

All patients provided written informed consent prior to enrollment.

Additional information

Editor-in-Chief Enrique Lara-Pezzi oversaw the review of this article

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Revuelta-López, E., Lupón, J., Lax, A. et al. Differences in the Interleukin-1β/Soluble ST2 Interplay Between Acute and Chronic Heart Failure. J. of Cardiovasc. Trans. Res. 13, 864–866 (2020). https://doi.org/10.1007/s12265-020-09958-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12265-020-09958-7

Keywords

Search

Navigation